Nicotine Science and Policy

Prohibition can give the impression of control while making the underlying risks harder to manage. When legal access to safer nicotine products is restricted, demand does not disappear; it can shift towards illicit supply, misinformation or continued cigarette use. That is where public health loses ground: not in the intention to reduce harm, but in the failure to account for real-world behaviour. Effective policy should reduce risk where people actually are, not where theory assumes they should be.

Safer nicotine did not appear out of nowhere. Its history is shaped by smokers looking for alternatives, scientists measuring risk, and policies that often struggled to keep up with both. From snus to vaping and nicotine pouches, the same lesson keeps returning: removing combustion can change the health equation. Understanding that history matters, because the future of tobacco policy should not repeat the mistakes that kept cigarettes at the centre for so long.

Italy and Greece challenge Ireland's proposed strict regulations on nicotine products, citing concerns about EU market coordination. The dispute centers on balancing public health goals with market harmonization. Ireland aims to enhance controls on vapes and nicotine pouches, focusing on marketing, packaging, and sales restrictions. This conflict highlights the evolving fragmentation of European nicotine regulations, affecting companies operating across the region. The objections emphasize the need for harmonizing national rules with EU frameworks. The debate underscores the challenges of aligning public health objectives with single market principles in the nicotine industry.

Surprise from the vaping sector points to a wider problem: policy is moving faster than the evidence conversation. When responsible retailers and manufacturers are treated as obstacles rather than part of the regulated solution, the legal market becomes weaker and the illicit market gains room. A serious approach should separate youth access, enforcement failures and adult switching instead of folding them into one blunt narrative. Regulation works best when it brings credible actors into accountability, not when it pushes them to the margins.

Cancer risk should not be discussed through headlines alone. New modelling on vaping and future cancer burden raises important questions about long-term outcomes, but it also depends on the comparison being made: continued smoking, complete cessation, dual use or full switching. The crucial distinction remains combustion, which drives the overwhelming burden of tobacco-related cancer. Public health communication should examine emerging risks without obscuring the far greater danger of cigarettes.